HIGHLIGHTS
- who: Minjeong Nam and collaborators from the Department of Laboratory Medicine, Korea University Anam Hospital, Seoul, Republic of Korea have published the research: Clinical Impact of Recipient-Derived Isoagglutinin Levels in ABO-Incompatible Hematopoietic Stem Cell Transplantation, in the Journal: (JOURNAL) of 31/07/2022
- what: The authors compared clinical outcomes such as survival GVHD infection relapse transfusion and engraftment among ABO-compatible patients (ABOc) patients (ABOi) with low RDI and ABOi patients with high RDI. This is the first study underscoring high RDI levels as a marker predicting unfavorable outcomes in ABOi HSCT. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.